International Congress Munich 2014

Saturday, 06.09.2014 Sunday, 07.09.2014 Monday, 08.09.2014 Tuesday, 09.09.2014 Wednesday, 10.09.2014		Sponsored symposia: Boehringer Ingelheim Evening Symposium: "Identifying the unmet needs in asthma: Who, why and how many?" Bayer Expert Forum: “Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in Non-CF Bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.

Oral Presentation
Chairs: M. Roberts (London, United Kingdom), S. Hartl (Vienna, Austria)

A systematic review of cost-effectiveness and quality derived from models evaluating smoking cessation interventions in patients with COPD F. Kirsch (Munich, Germany)
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia S. Spoorenberg, W. J. Bos, R. Heijligenberg, P. Voorn, J. Grutters, G. Rijkers, E. Van de Garde (Nieuwegein, Ede, Netherlands)
The impact of miscoding of community -acquired pneumonia in a UK district general hospital N. Gildeh, T. Errington, I. Maxwell, S. Merritt, D. Maxwell, O. Kankam (St Leonards on Sea, United Kingdom)
Medication reconciliation as warranty of improvement in patient care L. Saldaña, M. C. Herrero, M. V. Hernández, B. Steen, S. Sanz, M. Izquierdo, E. Pérez-F (Madrid, Spain)
Transcutaneous pCO₂ monitoring as an alternative to arterial line sampling: A cost-effectiveness analysis J. van Oppen, M. Sovani (Nottingham, United Kingdom)